270 related articles for article (PubMed ID: 20506408)
1. Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia.
Huijgen R; Kindt I; Fouchier SW; Defesche JC; Hutten BA; Kastelein JJ; Vissers MN
Hum Mutat; 2010 Jun; 31(6):752-60. PubMed ID: 20506408
[TBL] [Abstract][Full Text] [Related]
2. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
Fouchier SW; Kastelein JJ; Defesche JC
Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
4. Assessment of carotid atherosclerosis in normocholesterolemic individuals with proven mutations in the low-density lipoprotein receptor or apolipoprotein B genes.
Huijgen R; Vissers MN; Kindt I; Trip MD; de Groot E; Kastelein JJ; Hutten BA
Circ Cardiovasc Genet; 2011 Aug; 4(4):413-7. PubMed ID: 21642693
[TBL] [Abstract][Full Text] [Related]
5. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
7. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
[TBL] [Abstract][Full Text] [Related]
8. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of familial hypercholesterolemia in German and Greek patients.
Dedoussis GV; Genschel J; Bochow B; Pitsavos C; Skoumas J; Prassa M; Lkhagvasuren S; Toutouzas P; Vogt A; Kassner U; Thomas HP; Schmidt H
Hum Mutat; 2004 Mar; 23(3):285-6. PubMed ID: 14974088
[TBL] [Abstract][Full Text] [Related]
10. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
[TBL] [Abstract][Full Text] [Related]
11. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
Tybjaerg-Hansen A; Jensen HK; Benn M; Steffensen R; Jensen G; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):211-5. PubMed ID: 15528480
[TBL] [Abstract][Full Text] [Related]
12. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
Khoo KL; Van Acker P; Tan H; Deslypere JP
Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN
J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687
[TBL] [Abstract][Full Text] [Related]
14. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis in 46 German families with familial hypercholesterolemia: identification of 8 new mutations. Mutations in brief no. 226. Online.
Ebhardt M; Schmidt H; Doerk T; Tietge U; Haas R; Manns MP; Schmidtke J; Stuhrmann M
Hum Mutat; 1999; 13(3):257. PubMed ID: 10090484
[TBL] [Abstract][Full Text] [Related]
17. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
[TBL] [Abstract][Full Text] [Related]
18. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH.
Huijgen R; Hutten BA; Kindt I; Vissers MN; Kastelein JJ
Circ Cardiovasc Genet; 2012 Jun; 5(3):354-9. PubMed ID: 22553281
[TBL] [Abstract][Full Text] [Related]
19. Screening for mutations in the LDL receptor gene and apolipoprotein B-100 gene in 218 patients with severe hypercholesterolemia.
Geisel J; Holzem G; Schleifenbaum T; Oette K
Z Gastroenterol; 1996 Jun; 34 Suppl 3():14-5. PubMed ID: 8767447
[TBL] [Abstract][Full Text] [Related]
20. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
Miserez AR; Martin FJ; Spirk D
Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
